Table 2.
Effects of double agonist application on Aβ-induced reduction of AMPA receptor surface expression
| Normalized ratio of surface/input levels | |
|---|---|
| GluA1 | |
| sAβ42 | 1.00 |
| sAβ42+NS-3861+PNU-282987 | 1.06 ± 0.32 |
| sAβ42+PNU-282987+RJR-2403 Oxalate | 1.09 ± 0.26 |
| sAβ42+RJR-2403 Oxalate+NS-3861 | 1.04 ± 0.70 |
| oAβ42 | 0.39 ± 0.08 |
| oAβ42+NS-3861+PNU-282987 | 0.50 ± 0.15 |
| oAβ42+PNU-282987+RJR-2403 Oxalate | 1.21 ± 0.45 |
| oAβ42+RJR-2403 Oxalate+NS-3861 | 0.53 ± 0.23 |
| GluA2 | |
| sAβ42 | 1.00 |
| sAβ42+NS-3861+PNU-282987 | 1.28 ± 0.65 |
| sAβ42+PNU-282987+RJR-2403 Oxalate | 1.02 ± 0.18 |
| sAβ42+RJR-2403 Oxalate+NS-3861 | 1.00 ± 0.67 |
| oAβ42 | 0.38 ± 0.09 |
| oAβ42+NS-3861+PNU-282987 | 0.38 ± 0.08 |
| oAβ42+PNU-282987+RJR-2403 Oxalate | 1.12 ± 0.47 |
| oAβ42+RJR-2403 Oxalate+NS-3861 | 0.49 ± 0.19 |